Taking Leqembi Isn’t Enough: Only 3% of Early Alzheimer’s Patients Follow Recommended Lifestyle Habits
The arrival of disease-modifying treatments capable of slowing Alzheimer’s progression has offered patients newfound hope.
Search results for "lecanemab"
Slowing the Inevitable: How Early Antibody Therapy Is Transforming Alzheimer’s Care
“Lately, I keep forgetting appointments.” “They keep repeating what they just said.” When memory lapses in a parent become noticeable, families...
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?
American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment...
Mild Cognitive Impairment Doesn’t Always Lead to Dementia—Early Diagnosis and Lifestyle Management Are Key
Sept. 21 marks Dementia Overcoming Day, a designated observance created to raise public awareness about preventing and...
New Blood Test Accurately Predicts Alzheimer’s Progression, Pinpointing Optimal Candidates for Treatment
Dementia medications do not yield uniform results for every patient; instead, their clinical efficacy depends heavily...
“65% of Dementia-Causing Protein Removed Without Drugs” Could Ultrasound Offer New Hope?
A South Korean research team has succeeded in removing a key substance implicated in Alzheimer’s disease using...
"65% Reduction of Dementia-Causing Protein Without Drugs" Ultrasound, A New Hope?
A domestic research team has succeeded in removing the causative substances of Alzheimer's disease using ultrasound.
1